Interesting comparison to RAP.
MEB has already completed trials at a prestigious USA hospital, submitted for FDA regulatory approval, signed commercial arrangements, and has a commercially driven CEO based in the heart of Med Tech opportunities - USA. It too also has blue sky potential but it trades at a significant discount to RAP. Perhaps the higher cash burn is still playing a role in this.
The sell side looks very thin and if Jack can deliver on his promised opportunities he mentioned in the 1/4ly update it should rerate imo.
- Forums
- ASX - By Stock
- TRI
- Big liiiinnee!!
Big liiiinnee!!, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $8.683M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $571 | 30.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17504 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 171042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17504 | 0.020 |
1 | 20104 | 0.019 |
6 | 515555 | 0.018 |
3 | 505263 | 0.017 |
2 | 53000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 171042 | 1 |
0.022 | 203847 | 2 |
0.023 | 185145 | 2 |
0.024 | 29166 | 1 |
0.026 | 20000 | 1 |
Last trade - 13.12pm 07/10/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |